If you have been researching prescription weight loss options, you have almost certainly come across two names: semaglutide and tirzepatide. These GLP-1 medications have changed the landscape of medical weight loss over the past several years, delivering results that were once considered impossible without surgery. But patients across Southern New Hampshire frequently ask the same question: which one is better, and which one is right for me?
The honest answer is that it depends on your individual health profile, your weight loss goals, and what your provider recommends after a full medical evaluation. At Transition Medical Weight Loss in Salem NH, our clinical team helps patients navigate exactly this decision every day, backed by lab work, body composition analysis, and personalized care plans.
April is Stress Awareness Month and Move More Month, both national observances that are deeply connected to weight and metabolic health. Chronic stress drives cortisol levels up, which promotes fat storage and disrupts sleep. A sedentary lifestyle compounds those effects. For many patients, prescription weight loss medications are the medical tool that finally makes consistent progress possible, even in the context of stressful, busy lives. This month is a great time to get informed about your options.
What Are GLP-1 Medications?
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in response to eating. It signals the brain to reduce appetite, slows how quickly your stomach empties, and supports blood sugar regulation. GLP-1 receptor agonist medications mimic this hormone at therapeutic levels, meaning they amplify these effects in a way that supports meaningful, sustained weight loss.
Both semaglutide and tirzepatide are injectable, once-weekly prescription weight loss medications. Both require a prescription and ongoing medical supervision to be used safely and effectively. That is why access to these medications through a doctor supervised weight loss program is so important. The right dosing, monitoring, and clinical support can make the difference between a positive experience and one that falls short of your goals.
Semaglutide: What It Is and How It Works
Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes) and Wegovy (approved specifically for chronic weight management). As a GLP-1 receptor agonist, semaglutide targets the appetite-regulating centers of the brain, reduces food cravings, and promotes feelings of fullness after smaller meals.
In clinical trials, patients using semaglutide for weight loss lost an average of 15 percent or more of their body weight over the course of a year when combined with lifestyle modifications. For someone weighing 220 pounds, that represents a potential loss of 33 or more pounds under proper medical supervision.
Semaglutide is typically started at a low dose and titrated gradually upward to minimize side effects, which most commonly include nausea, mild digestive discomfort, and fatigue, particularly in the early weeks of treatment. These effects tend to lessen as the body adjusts.
Tirzepatide: What It Is and How It Works
Tirzepatide is the active ingredient in Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management). It represents the next generation of GLP-1 based therapy. Unlike semaglutide, which acts on only the GLP-1 receptor, tirzepatide is a dual agonist that also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor.
GIP is another gut hormone involved in metabolism and fat storage. By targeting both GLP-1 and GIP receptors simultaneously, tirzepatide appears to produce a more powerful combined effect on appetite suppression and metabolic function.
In clinical trials, patients on tirzepatide lost an average of 20 to 22 percent of their body weight over approximately 72 weeks. Some participants lost significantly more. These numbers have made tirzepatide one of the most talked-about prescription weight loss options available today.
Semaglutide vs. Tirzepatide: How Do They Compare?
Both medications are effective. Both require once-weekly injections. Both are prescription-only and must be used under medical supervision. Here is how they differ in key areas:
- Mechanism: Semaglutide activates GLP-1 receptors only. Tirzepatide activates both GLP-1 and GIP receptors.
- Average weight loss: Semaglutide studies show approximately 15 percent body weight reduction. Tirzepatide studies show approximately 20 to 22 percent, with some patients achieving more.
- Side effect profile: Both medications share a similar side effect profile dominated by GI symptoms like nausea, vomiting, and constipation. Tirzepatide’s dual mechanism may produce slightly different tolerability in some individuals.
- Insurance coverage: Coverage varies by plan and diagnosis. The team at Transition handles prior authorization efforts for both medications as part of the program.
- Cost: Without insurance, both medications are expensive. Insurance coverage through plans like Anthem, UnitedHealthcare, or Aetna can significantly reduce or eliminate out-of-pocket costs.
It is worth noting that head-to-head clinical trials comparing the two medications directly are ongoing, and the science continues to evolve. What matters most is not which medication wins on paper, but which one is appropriate for your specific body, health history, and goals.
Which Medication Is Right for You?
This is not a decision that should be made based on a social media post or an online quiz. Choosing between semaglutide and tirzepatide requires a clinical conversation that takes into account your current weight, medical history, metabolic markers, any existing conditions like insulin resistance or type 2 diabetes, your response to previous weight loss attempts, and your insurance coverage.
At Transition Medical Weight Loss, every patient starts with a comprehensive medical evaluation that includes lab work and body composition analysis. This gives our providers the clinical data they need to recommend the right medication at the right dose, and to monitor your progress safely over time.
Both in-person and virtual patients have access to prescription weight loss medications as part of their medically managed weight loss program. If you are located in Salem NH, Windham, Derry, or anywhere in Rockingham County, you do not have to figure this out alone.
What Happens If I Stop Taking the Medication?
This is one of the most common and important questions patients ask. Research shows that many people do regain weight after stopping GLP-1 medications if no other interventions are in place. This is exactly why these medications should be used as part of a comprehensive program that includes nutrition education, behavioral support, and a long-term maintenance strategy.
At Transition Medical Weight Loss, the program does not end when your active weight loss phase does. Patients transition into a maintenance plan designed to preserve results, build sustainable habits, and provide ongoing accountability. The goal has always been lasting change, not a quick fix.
Our in-person program and virtual Transition Anywhere program both incorporate the lifestyle education and behavioral support that make the difference between short-term results and permanent transformation.
Stress, Movement, and Weight Loss: The April Connection
April is Stress Awareness Month for good reason. Chronic stress is one of the most underrecognized drivers of weight gain and weight loss resistance. When cortisol stays elevated, the body is chemically inclined to store fat, crave high-calorie foods, and resist the hormonal signals that promote satiety.
GLP-1 medications can help break that cycle by chemically reducing appetite and food noise, making it easier to stick to healthy habits even when stress is high. Combined with the behavioral and psychological support provided through the Transition program, including access to our social worker and counselor, patients are equipped to address both the physical and emotional dimensions of weight.
Move More Month is a reminder that physical activity does not have to be extreme to be effective. Even moderate movement supports metabolic health, improves insulin sensitivity, and complements the effects of GLP-1 therapy. All Transition patients receive a custom fitness plan as part of their program, with options designed for every starting point and fitness level.
Why Salem NH Patients Trust Transition Medical Weight Loss
Transition Medical Weight Loss has been serving patients in Salem NH and throughout Southern New Hampshire for over 30 years. Under the direction of Medical Director Dr. Azar Korbey, the clinical team includes licensed physicians, physician assistants, a registered dietitian, and a licensed counselor, giving patients a full spectrum of support.
The practice is now in-network with Anthem Blue Cross Blue Shield, Harvard Pilgrim, UnitedHealthcare, Aetna, Cigna, Ambetter, and Mass General Brigham Health Plans, making insurance-covered access to prescription weight loss care more accessible than ever for patients throughout Rockingham County, Windham, Derry, and beyond.
If you are ready to have a real conversation about semaglutide, tirzepatide, or what a medically supervised weight loss program could look like for you, book your first appointment today.
Frequently Asked Questions
1. Is tirzepatide stronger than semaglutide for weight loss?
Clinical trial data suggests tirzepatide produces greater average weight loss than semaglutide, largely because it activates both the GLP-1 and GIP receptors rather than just GLP-1. However, individual responses vary, and the best medication for you depends on your personal health profile, not trial averages. Your provider at Transition Medical Weight Loss will recommend the right option based on your evaluation.
2. Are GLP-1 weight loss injections safe?
When used under proper medical supervision, GLP-1 medications have a well-established safety record. The most common side effects are gastrointestinal and tend to decrease over time. Like any prescription medication, they are not appropriate for everyone, which is why a thorough medical evaluation before starting is essential. The clinical team at Transition oversees every patient’s progress and adjusts treatment as needed.
3. Will my insurance cover semaglutide or tirzepatide?
Coverage depends on your individual plan and diagnosis. Transition Medical Weight Loss is in-network with several major insurance providers and handles prior authorization efforts for prescription weight loss medications as part of the program. Visit the Our Plans page or call the office at (603) 685-0462 to find out what your plan covers.
4. How long do I need to take GLP-1 medications?
The duration of treatment varies by patient. Some people use GLP-1 medications for a defined period as part of an active weight loss phase, while others remain on them longer-term for weight management, particularly if weight regain is a clinical concern. Your provider will work with you to establish a plan that aligns with your health goals and personal preferences.
5. Can I access semaglutide or tirzepatide through the virtual program?
Yes. Patients enrolled in the Transition Anywhere virtual program have access to prescription weight loss medications, including GLP-1 injections, as part of their medically supervised plan. The virtual program delivers the same level of clinical oversight as in-person care, making it a strong option for patients throughout New Hampshire who prefer to participate remotely.
Ready to find out if semaglutide or tirzepatide is right for you? Schedule your first appointment at Transition Medical Weight Loss in Salem NH.